Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Postoperative circulating tumor DNA detection and CBLB mutations are prognostic biomarkers for gastric cancer.

Genes & genomics - 1 Aug 2023

Zhou Hekai, Liu Houcong, Li Jun, Wang Jidong, Fu Xiaohong, Li Yingqiang, Mao Shaolong, Du Jihui

Abstract excerpt

BACKGROUND: Several studies have demonstrated that circulating tumor DNA (ctDNA) can be used to predict the postoperative recurrence of several cancers. However, there are few studies on the use of ctDNA as a prognosis tool for gastric cancer (GC) patients. OBJECTIVE: This study aims to determine whether ctDNA could be used as a prognostic biomarker in GC patients through multigene-panel sequencing. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Share to Proto-Oncogene Proteins c-cbl

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 37306927
DOI: 10.1007/s13258-023-01412-7
PMCID: PMC10349697

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Postoperative circulating tumor DNA detection and CBLB mutations are prognostic biomarkers for gastric cancer.PMID 37306927Read ↗

Clinical significance of circulating plasma DNA in gastric cancerSemantic proximity Read ↗

Clinical applications and perspectives of circulating tumor DNA in gastric cancerSemantic proximity Read ↗

Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancersSemantic proximity Read ↗

The Role of ctDNA in Gastric CancerSemantic proximity Read ↗

Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancerSemantic proximity Read ↗

Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker studySemantic proximity Read ↗

New blood markers detection technology: A leap in the diagnosis of gastric cancer.Semantic proximity Read ↗

Monitoring gastric cancer progression with circulating tumour DNASemantic proximity Read ↗

Evaluation of ctDNA in Predicting Response to Neoadjuvant Therapy and Analysis of Residual Disease in Local Advanced Gastric Cancer: Protocol of A Single-Arm Multicenter Prospective Observational StudySemantic proximity Read ↗

The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitorsSemantic proximity Read ↗

Detection of circulating tumor DNA in patients of operative colorectal and gastric cancersSemantic proximity Read ↗

Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.